|
- IRMS - Nicolae Testemitanu SUMPh
- REVISTE MEDICALE NEINSTITUȚIONALE
- Sănătate Publică, Economie şi Management în Medicină
- Sănătate Publică, Economie şi Management în Medicină 2016
- Sănătate Publică, Economie şi Management în Medicină Nr. 2 (66) / 2016
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/1509
Title: | Proceduri endoscopice și terapia antitrombotică |
Other Titles: | Endoscopy in patients on antithrombotic agents (literature review Эндоскопические процедуры и антитромботическая терапия (обзор литературы) |
Authors: | Nani, Anastasia Samohvalov, Elena Grib, Liviu Tcaciuc, Angela Mercaciova, Maria Rotari, Olga Grejdieru, Alexandra Samohvalov, Sergiu Sumarga, Natalia |
Keywords: | glycoprotein IIb/IIIa receptor inhibitors;warfarin;endoscopy |
Issue Date: | 2016 |
Publisher: | Asociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldova |
Citation: | NANI, Anastasia, SAMOHVALOV, Elena, GRIB, Liviu, TCACIUC, Angela, MERCACIOVA, Maria, ROTARI, Olga, GREJDIERU, Alexandra, SAMOHVALOV, Sergiu, SUMARGA, Natalia. Proceduri endoscopice și terapia antitrombotică. In: Sănătate Publică, Economie şi Management în Medicină. 2016, nr. 2(66), pp. 77-80. ISSN 1729-8687. |
Abstract: | The antithrombotic treatment is widely used in medicine – cardiology, internal medicine, gynecology, surgery, traumatology, interventional cardiology, etc. It’s effectiveness has been demonstrated by many clinical studies. This article reveals the problem of the relationship between antithrombotic therapy and endoscopic procedures. For patients taking these medications that had require endoscopy, doctor should consider the following important factors: (1) the urgency of the procedure, (2) bleeding risk of the procedure, (3) the effect of the antithrombotic drugs on the bleeding risk, and (4) the risk of a thromboembolic events, related to per procedural interruption of antithrombotic agents. These issues require close collaboration of cardiologists and gastroenterologists, and individual approach to the treatment of such patients. Антитромботическое лечение широко используется в медицине – в кардиологии, терапии, гинекологии, хирургии, травматологии, интервенционной кардиологии и др. Его эффективность была доказана во многих клинических исследованиях. В данной статье раскрываются проблемы взаимосвязи антитромботического лечения с эндоскопическими процедурами, перед проведением которых необходимо иметь ввиду: срочность проведения эндоскопической процедуры, риск кровотечения при проведении этой процедуры, риск кровотечения при непосредственном применении антитромботического лечения, риск осложнений при отмене антитромботического лечения. Данные вопросы требуют тесного сотрудничества кардиологов и гастроэнтерологов и индивидуального подхода к лечению таких пациентов. |
URI: | http://repository.usmf.md/handle/20.500.12710/1509 http://revistaspemm.md/wp-content/uploads/2019/05/cm2_66_2016cg.pdf |
ISSN: | 1729-8687 |
Appears in Collections: | Sănătate Publică, Economie şi Management în Medicină Nr. 2 (66) / 2016
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|